Chemoprophylaxis of group B streptococcal infections

Chemoprophylaxis of early-onset group B streptococcal disease in 1999.

Current opinion in pediatrics·2000

Prevention of neonatal necrotizing enterocolitis.

Clinics in perinatology·1994

Development of IgM antibody to group B Streptococcus type III in human infants.

The Journal of infectious diseases·1992

Antimicrobial prophylaxis of neonatal group B streptococcal sepsis.

Clinics in perinatology·1988

Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.

The New England journal of medicine·1986

Human IgG antibody to group b Streptococcus type III: comparison of protective levels in a murine model with levels in infected human neonates.

The Journal of infectious diseases·1986

Persistent candidemia matters: risk factors and clinical outcomes in a retrospective matched cohort study.

Infection·2026

A retrospective study of alternative antibiotics for prophylaxis of the Group B Streptococcus maternal-fetal disease.

Infection·2026

Outcomes and associated risk factors among hospitalisations attributed to invasive group A streptococcal disease in Northern Queensland, Australia: a 21-year population-based data linkage study.

Infection·2026

Impact of time from symptom onset to diagnosis in infective endocarditis: insights from the nationwide NIDUS registry.

Infection·2026

Clinical utility of time to positivity in candidemia: prognostic limitations and species-specific implications.

Infection·2026

Immunosuppressive medication exposure and risk of invasive fungal and nontuberculous mycobacterial infections following TNF-α inhibitor initiation: a time-varying analysis.

Infection·2026

Aluminum-based salts: an unorthodox but simple way to treat molluscum contagiosum and cutaneous warts.

F1000Research·2026

Post-diagnosis cannabis use and its association with health status and quality of life in cancer survivors.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Aloesin mitigates cisplatin-induced nephrotoxicity by suppressing NF-κB-mediated oxidative stress and modulating Bax/Bcl-2/caspase pathways.

Naunyn-Schmiedeberg's archives of pharmacology·2026

[Immune checkpoint inhibition plus Bacillus Calmette-Guerin (BCG) therapy in BCG-naive high-risk non-muscle-invasive bladder cancer: a critical review in the context of current evidence].

Urologie (Heidelberg, Germany)·2026

ITGA5 promotes homologous recombination mediated radioresistance in esophageal squamous cell carcinoma by upregulating RAD51AP1 expression.

Oncogene·2026

Comparison of venetoclax and azacitidine versus a cytarabine-based treatment for patients with acute myeloid leukaemia in first relapse after chemotherapy. A real-world study of the DATAML-IPC-AURAML consortium.

British journal of haematology·2026

Related Experiment Videos

Chemoprophylaxis of group B streptococcal infections

Related Concept Videos

Chemoprophylaxis of early-onset group B streptococcal disease in 1999.

Prevention of neonatal necrotizing enterocolitis.

Development of IgM antibody to group B Streptococcus type III in human infants.

Antimicrobial prophylaxis of neonatal group B streptococcal sepsis.

Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.

Human IgG antibody to group b Streptococcus type III: comparison of protective levels in a murine model with levels in infected human neonates.

Persistent candidemia matters: risk factors and clinical outcomes in a retrospective matched cohort study.

A retrospective study of alternative antibiotics for prophylaxis of the Group B Streptococcus maternal-fetal disease.

Outcomes and associated risk factors among hospitalisations attributed to invasive group A streptococcal disease in Northern Queensland, Australia: a 21-year population-based data linkage study.

Impact of time from symptom onset to diagnosis in infective endocarditis: insights from the nationwide NIDUS registry.

Clinical utility of time to positivity in candidemia: prognostic limitations and species-specific implications.

Immunosuppressive medication exposure and risk of invasive fungal and nontuberculous mycobacterial infections following TNF-α inhibitor initiation: a time-varying analysis.

Aluminum-based salts: an unorthodox but simple way to treat molluscum contagiosum and cutaneous warts.

Post-diagnosis cannabis use and its association with health status and quality of life in cancer survivors.

Aloesin mitigates cisplatin-induced nephrotoxicity by suppressing NF-κB-mediated oxidative stress and modulating Bax/Bcl-2/caspase pathways.

[Immune checkpoint inhibition plus Bacillus Calmette-Guerin (BCG) therapy in BCG-naive high-risk non-muscle-invasive bladder cancer: a critical review in the context of current evidence].

ITGA5 promotes homologous recombination mediated radioresistance in esophageal squamous cell carcinoma by upregulating RAD51AP1 expression.

Comparison of venetoclax and azacitidine versus a cytarabine-based treatment for patients with acute myeloid leukaemia in first relapse after chemotherapy. A real-world study of the DATAML-IPC-AURAML consortium.

Related Experiment Videos

Chemoprophylaxis of group B streptococcal infections

Related Concept Videos

Related Articles